Association of Amyloid and Tau With Cognition in Preclinical Alzheimer DiseaseBernard Hanseeuw, Keith A. Johnson, Rebecca A. Betensky et al.|JAMA Neurology|2019Cited by 876
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case reportJoseph F. Arboleda‐Velásquez, Yakeel T. Quiroz, Francisco Lopera et al.|Nature Medicine|2019Cited by 606
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control studyEric M. Reiman, Francisco Lopera, Yakeel T. Quiroz et al.|The Lancet Neurology|2012Cited by 553
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementiaMiia Kivipelto, Rema Raman, Lenore J. Launer et al.|Alzheimer s & Dementia|2020Cited by 516
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological studyEric M. Reiman, Clinton T. Baldwin, Joseph F. Arboleda‐Velásquez et al.|Nature Communications|2020Cited by 493